clinical support News
-
QURE Healthcare Announces Launch of Primary Care Engagement and Care Transformation Project with VillageMD
QURE Healthcare, Inc. a leader in quality measurement and clinician engagement, announced the launch of a comprehensive project with VillageMD: The VillageMD-QURE Performance and Variation Improvement (VQ-PVI) Partnership—a nationwide quality framework for continual engagement of primary providers (MD/DO/NP/PA) and clinical and non-clinical support teams (RNs LPNs, MAs). Under the ...
-
Official launch of the D25
In May 2020, the D25 was officially launched. Fully certified and supported by clinical research. We are very proud to announce the official launch of the UV Smart D25! The D25 is a device supported by our Impelux™ technology and is designed to disinfect non-invasive medical devices in 25 seconds using UV-C light. The D25 is validated, certified (medical device class Ila) and supported ...
-
dBMEDx™ Announces Supply Agreement with Bard / BD
dBMEDx, Inc., a privately-held, wireless medical device company, announced today that it has entered into a definitive supply agreement with C. R. Bard, a subsidiary of BD (Becton, Dickinson and Company, NYSE: BDX). Under the agreement, Bard/BD will be the exclusive US distributor of the BBS RevolutionTM bladder scanner for the hospital and urology markets. The dBMEDx BBS RevolutionTM bladder ...
By dBMEDx
-
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network
Biobeat is excited to join forces with Medidata Solutions and be part of the Sensor Cloud Network. By using Biobeat’s medical-grade wearables we are able to enhance clinical trials with vital signs collection to generate real-world evidence remotely and conveniently from the patient’s home. Our platform supports decentralized clinical trials and significantly reduces the logistics ...
-
RTsafe and Medical Physics Limited seal their cooperation with a double agreement: Distribution in the UK and provision of commercial and auditing services internationally
ATHENS, Greece, November 24, 2021 Following our successful cooperation since 2018, we are excited to announce that RTsafe and Medical Physics Limited expand their cooperation by entering into a partnership agreement under which Medical Physics Limited will be the agent of RTsafe’s innovative solutions for quality assurance in radiotherapy in the United Kingdom. Moreover, our partnership ...
By RTsafe
-
AxioSonic will be presenting at AAO-HNSF Annual Meeting & OTO Expo
Vivek Ramakrishnan will be presenting at AAO-HNSF on a poster titled: “Treatment of Rhinosinusitis with Topical Ultrasound”. The poster summarizes data from a clinical study supporting the use of therapeutic ultrasound for treatment in facial pain in patients diagnosed with chronic rhinosinusitis. The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) ...
-
Quarterly Activities Report and 4C Quarterly Cash Flow Report
Botanix (ASX:BOT) has today published its Quarterly Activities Report and 4C Quarterly Cash Flow Report, for the period ended 31 March 2022 Key highlights from this period include: Strategic appointments to Botanix’s executive leadership team,including Dr Patty Walker as Chief Medical Officer and Mr Howie McKibbon as Chief Commercial Officer Danny Sharp also joins as Non-Executive ...
-
Betalin Therapeutics establishes UK subsidiary
BetalinUK was establish in August of 2020 in Leeds, United Kingdom. In order to initiate research, we’ve been working hard to secure funding to help accelerate our pre-clinical research. BetalinUK has been awarded a Leeds City Region Enterpise Partnership (LEP) greant, #Welcome. This grant has allowed BetalinUK to establish the lab at NEXUS to being work. In addition to ...
-
Novadiscovery appoints Gregoire Boutonnet as Chief Operating Officer
Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. In his new role, Grégoire will ensure alignment between NOVA’s business strategy, operations and growth objectives, as well ...
-
Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, announced today that the Company will present at H.C. Wainwright BioConnect and participate in Biotech Showcase and BIO Partnering at JPM. All three ...
By CervoMed
-
Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today a new clinical study supporting the efficacy of their blood culture collection product. Authors from Guy’s and St. Thomas’ NHS Foundation Trust, a prestigious London-based hospital, presented their data at the recent Infection Prevention Society conference in ...
By Kurin, Inc.
-
Relievant Medsystems Names Tyler Binney President and CEO
Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the appointment of Tyler Binney as President and Chief Executive Officer. Mr. Binney will also join Relievant’s Board of Directors. Arthur Taylor, who previously held the CEO position on an interim basis, will return to his role on the Board of Directors. ...
-
SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced a collaboration with KaliVir Immunotherapeutics to make TPOXX® (tecovirimat) available for use with KaliVir’s proprietary oncolytic vaccinia immunotherapy platform. This novel oncolytic platform ...
-
PeriGen Deploys Mobile Version of PeriWatch Vigilance to Further Protect Moms and Babies During Childbirth
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today introduced PeriWatch Vigilance® Mobile, a full-function browser-based solution providing access to its early warning system (EWS) and clinical decision support tool. By providing remote access to the full range of conditions monitored by PeriWatch Vigilance, the new solution ...
-
EU allergy and asthma network marks its achievements
The Global Allergy and Asthma European Network (GA2LEN)1, established in 2005 to facilitate excellence in allergy research across clinical and research institutions in Europe, has recently published a report on its major achievements. Funded by the EU, GA2LEN is composed of a multidisciplinary research network centred on scientific projects in allergy and asthma. It integrates research on ...
-
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a new collaboration with “Takeda Pharmaceutical Company Limited (“Takeda”) aimed at incorporating clinical simulation technology on virtual ...
-
Micron receives additional funding from the CDC for collaboration on the development of a microneedle patch for IRV-IPV co-administration
ATLANTA, August 27, 2018 – Micron Biomedical, Inc. (Micron) was awarded a new research contract by the Centers for Disease Control and Prevention (CDC) to continue the development of an IRV-IPV microneedle patch and its GMP manufacturing process. This new research contract comes after Micron successfully completed a Phase 1 SBIR grant and a research contract with the CDC for the ...
-
Durable Healing Outcomes of Topical Wound Oxygen (TWO2) Therapy Highlighted at Leading International Clinical Conferences
Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the United States and United Kingdom. AOTI participated both as a sponsor and exhibitor at these events that were conducted in a hybrid format, where attendance could be either in person, or ...
-
Dutch research institutions and Elsevier initiate world`s first national Open Science partnership
The Association of Universities in the Netherlands (VSNU), The Netherlands Federation of University Medical Centres (NFU), The Dutch Research Council (NWO) and Elsevier, a global leader in research publishing and information analytics, have formed a novel partnership that includes publishing and reading services as well as the joint development of new open science services for disseminating and ...
-
iRhythm launches Clinical Resource Center for clinicians’ convenience
iRhythm Technologies, Inc. is excited to announce the addition of a Clinical Resource Center (CRC) to its website. The CRC was designed to make it easy for clinicians to access clinical evidence, on-demand webinars, and case studies through one centralized location. Clinicians will use the CRC as a gateway to published clinical articles. Summaries of significant ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you